Dennis R. Cryer, MD, FAHA
Chief Medical Officer, CryerHealth
Dr. Dennis Cryer received his undergraduate degree from Johns Hopkins University and completed his medical education at the Albert Einstein College of Medicine. He received his residency training in pediatrics at the Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine. The recipient of a research fellowship in Molecular Biology and a clinical research fellowship in Human Genetics and Metabolism at the Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine.
Dr. Cryer joined Bristol-Myers Squibb in 1987 where he had an expansive career over 20 years. In 1993, his team led the licensing and medical development of metformin (Glucophagea), an oral antidiabetic agent, for launch in the U.S. It has subsequently become first line therapy for Type II diabetes. In 1996, Dr. Cryer’s responsibilities were expanded to include the Women’s Health Care area, and he was promoted to Vice President. He was subsequently named Vice President, External Medical Affairs. He left Bristol-Myers Squibb in 2007 to join Indigo Pharmaceuticals in New York. Dr. Cryer has served as Chief Medical Officer of CryerHealth, a patient-centric strategic consulting firm in Washington, DC, serving the breadth of the healthcare community in the U.S. and internationally.
Dr. Cryer currently serves on the Board of Directors of the Sister to Sister Foundation, is Treasurer and member of the Board of Directors of the Friends of the National Library of Medicine (NIH), and is Secretary/Treasurer and member of the Board of Directors of the Society for Women’s Health Research.